The prevalence of glaucoma in indigenous Australians within Central Australia: the Central Australian Ocular Health Study

Aims To determine the prevalence of glaucoma within the indigenous Australian population living in central Australia. Methods 1884 individuals aged ≥20 years, living in one of 30 remote communities within the statistical local area of ‘Central Australia,’ were recruited for this study. This equated to 36% of those aged ≥20 years and 67% of those aged ≥40 years within this district. Slit-lamp examination of the anterior segment and intraocular pressure measurement, followed by stereoscopic slit-lamp funduscopy of the optic nerve, was performed. Selected patients underwent automated visual-field testing. The diagnosis of glaucoma was based on pre-existing definitions. Glaucoma prevalence data are presented. Results Seventeen individuals had glaucoma (0.90%). Causes of secondary glaucoma were found in four with neovascular glaucoma, two with uveitic glaucoma and four who had developed glaucoma subsequent to trauma or surgery. The remaining seven had no identifiable cause for their glaucoma and were thus classified as open-angle glaucoma equating to a prevalence of 0.52% (95% CI 0.14% to 0.90%) for those aged ≥40 years. Of these, four had an intraocular pressure ≤21 mm Hg, and three had an intraocular pressure >21 mm Hg. Conclusion The prevalence of open-angle glaucoma among indigenous Australians within central Australia was 0.52% for those aged ≥40 years. After adjustment for the age distribution of our sample, this is one-third the prevalence seen among the non-indigenous Australian population and is despite a higher prevalence of ocular parameters considered to be associated with glaucoma

Incidence of visual impairment due to cataract, diabetic retinopathy and trachoma in indigenous Australians within central Australia: the Central Australian Ocular Health Study

Author version made available in accordance with the publisher's policy.Background: To estimate the incidence and causes of visual impairment for the purposes of service provision among the indigenous Australian population within central Australia from its most common causes, namely cataract, diabetic retinopathy and trachoma. Design: Clinic-based cohort study. Participants: One thousand eight hundred eighty four individuals aged =20 years living in one of 30 remote communities within the statistical local area of 'Central Australia'. Methods: From those initially recruited, 608 (32%) participants were reviewed again between 6 months and 3 years (median 2 years). Patients underwent Snellen visual acuity testing and subjective refraction. Following this, an assessment of their anterior and posterior segments was made. Baseline results were compared with those who were reviewed. Main Outcome Measures: The annual incidence rates and causes of visual impairment (vision worse than Snellen visual acuity 6/12 in at least one eye). Results: The incidence of visual impairment in at least one eye was 6.6%, 1.2% and 0.7% per year for cataract, diabetic retinopathy and trachoma, respectively (7.9%, 1.5% and 0.7% per year for those aged =40 years). Advancing age was the main risk factor common to all three. Conclusion: It is important to be mindful not only of the prevalence of disease in a community but also of the rate at which new cases are occurring when allocating resources to address the ocular health needs of this region. Compared with historical data, diabetic retinopathy is emerging as a new and increasing threat to vision in this population.Australian National Health & Medical Research Counci

The Relationship Between Stride Rates, Lengths and Body Size and their Affect on Elite Triathletes’ Running Performance During Competition

Previous research has suggested that a degree of predictability exists in the relationship between self-selected running stride rates (SR) and stride lengths (SL) with measures of body size such as mass, height and limb lengths. Significant correlations have also been revealed between these body size measures and performance and between SL and performance. However, there is also evidence to suggest that triathlon performance may be related to maintaining a longer SL during the final run. Hence, the aim of this investigation was to examine whether there was any relationship between SR and SL, with body masses and heights of senior elite triathletes during the run stage of a triathlon. The SRs and SLs of 37 male senior elite Triathlon World Championships competitors were analysed via videography and Video Expert II Coach. These values were correlated with the athletes’ body masses and heights (p\u3c0.01). The results indicated a limited relationship between height and mass with SR in the early stages of the run. However, a significant, positive correlation existed between SL and height at all points from 3 km to the end of the run. Those triathletes who were taller used longer strides. Further research is warranted to examine the effects of cycling on the subsequent run discipline during triathlon and if body size and shape of triathletes have evolved as the young sport of triathlon develops

Cadence, Stride Rate and Stride Length During Triathlon Competition

Triathlon research shows cycling alters the physiological response of subsequent running but, at present, biomechanical changes are unresolved. This study examined cycling cadence and running stride rate (SR) and length (SL) used by senior elite triathletes during competition. These variables were then compared to running and triathlon performance. Data from 51 elite male World Championships triathletes were analysed via video recordings and Video Expert II Coach. Triathletes revealed consistent cadences throughout the majority of the cycle (96.8 +2.7 rpm) and run (90.9 +2.4 rpm) disciplines. However, a cadence increase (99.6 +5.7 rpm) was recorded at the completion of the cycle prior to running. Running SR and SL was significantly lower at the end of the run indicating a level of fatigue (p\u3c0.01). Running SL was significantly and positively correlated with running and triathlon performance (p\u3c0.01) suggesting those that could maintain a longer SL had a faster run and better final finishing position

Swim Positioning and its Influence on Triathlon Outcome

Questions have been raised regarding which of the three legs of a triathlon influences the final finishing position. Some coaches subjectively believe that the swim and run are more important than the cycle, especially since the introduction of drafting during the cycle. This study analysed race position shifts between each of the three disciplines to assess the importance of the swim finish position and final finish position during draft legal Olympic distance triathlon events. Ten male and 10 female triathlon world cup events during one season were analysed. The results suggested that the triathlon swim leg is important because the winner exited the water in the first pack in 90% of elite male and 70% of elite female races. Correlations were also derived from finishing order for the whole triathlon and a finishing order that included the swim only, cycle only or run only time. For men, the average correlations for final finishing order with each of the swim, cycle and run, respectively, were 0.49, 0.67 and 0.86 and for the women; average correlations were 0.39, 0.67 and 0.85. Hence, this indicated that it was important to exit the water in the first pack and run well after cycling to achieve a successful final finishing position

Educating Future Nursing Scientists: Recommendations for Integrating Omics Content in PhD Programs

Preparing the next generation of nursing scientists to conduct high-impact, competitive, sustainable, innovative, and interdisciplinary programs of research requires that the curricula for PhD programs keep pace with emerging areas of knowledge and health care/biomedical science. A field of inquiry that holds great potential to influence our understanding of the underlying biology and mechanisms of health and disease is omics. For the purpose of this article, omics refers to genomics, transcriptomics, proteomics, epigenomics, exposomics, microbiomics, and metabolomics. Traditionally, most PhD programs in schools of nursing do not incorporate this content into their core curricula. As part of the Council for the Advancement of Nursing Science\u27s Idea Festival for Nursing Science Education, a work group charged with addressing omics preparation for the next generation of nursing scientists was convened. The purpose of this article is to describe key findings and recommendations from the work group that unanimously and enthusiastically support the incorporation of omics content into the curricula of PhD programs in nursing. The work group also calls to action faculty in schools of nursing to develop strategies to enable students needing immersion in omics science and methods to execute their research goals

Brief of Intellectual Property Law Scholars As Amici Curiae in Support of Neither Party, WesternGeco LLC v. Ion Geophysical Corp., No. 16-1011, US Supreme Court

This amici curiae brief was filed on behalf of Intellectual Property Law Scholars in WesternGeco LLC v. Ion Geophysical Corp. in the U.S. Supreme Court. The question presented is: Whether the U.S. Court of Appeals for the Federal Circuit erred in holding that lost profits arising from prohibited combinations occurring outside of the United States are categorically unavailable in cases in which patent infringement is proven under 35 U.S.C. § 271(f). In RJR Nabisco, Inc. v. European Community, 136 S. Ct. 2090 (2016), the Supreme Court articulated a two-step method for assessing the extraterritorial reach of a US statute: 1. A court should determine whether the presumption against extraterritoriality has been rebutted—that is, whether the statute gives a clear, affirmative indication that it applies extraterritorially. If the presumption is rebutted, the statute may have extraterritorial reach. 2. But even if the presumption has not been rebutted, a court should look at the focus of the statute. If the conduct relevant to the statute\u27s focus occurred in the United States, then the case involves a permissible domestic application even if other conduct occurred abroad; but if the conduct relevant to the focus occurred in a foreign country, then the case involves an impermissible extraterritorial application regardless of any other conduct that occurred in U.S. territory. The brief of amici curiae makes the follow points: 1. The Supreme Court has not squarely answered the question as to whether the presumption against extraterritoriality applies separately to remedial provisions of a statute generally (here whether it applies to § 284). We argue it does. 2. We argue that the territorial reach § 284 necessarily depends the relevant provision of § 271 used to find liability. Here, under § 271(f), the presumption is rebutted (though it would not be generally for a case under § 271(a), with NTP v. Research in Motion may be a counter-example when one looks at the focus at step 2)). 3. We also argue that the Court should offer more guidance as to what happens even if the RJR test is satisfied. RJR Nabisco seems to operate in binary fashion -- either the statute has extraterritorial reach or it doesn\u27t. But Microsoft Corp. v. AT&T Corp., and earlier Supreme Court decision also interpreting 35 U.S.C. § 271(f), suggests that the presumption may still have a role in interpreting a statute. We offer two suggestions on how the presumption should operate in this context. First, courts should seriously and formally consider issues of comity and potential conflicts with foreign law in assessing whether to apply U.S. law extraterritorially. Second, that territoriality should remain relevant in assessments of proximate cause

Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial

Background Findings from the RESTART trial suggest that starting antiplatelet therapy might reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding antiplatelet therapy. Brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases (such as cerebral microbleeds) are associated with greater risks of recurrent intracerebral haemorrhage. We did subgroup analyses of the RESTART trial to explore whether these brain imaging features modify the effects of antiplatelet therapy